ArticleFrontiers in pharmacology2021

Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels.

Ruihua Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.